OS Therapies (OSTX) Competitors $1.74 -0.03 (-1.69%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends OSTX vs. DRUG, FTLF, NLTX, SGMT, ABOS, PBYI, BDTX, IVA, IPHA, and CDTXShould you be buying OS Therapies stock or one of its competitors? The main competitors of OS Therapies include Bright Minds Biosciences (DRUG), FitLife Brands (FTLF), Neoleukin Therapeutics (NLTX), Sagimet Biosciences (SGMT), Acumen Pharmaceuticals (ABOS), Puma Biotechnology (PBYI), Black Diamond Therapeutics (BDTX), Inventiva (IVA), Innate Pharma (IPHA), and Cidara Therapeutics (CDTX). These companies are all part of the "pharmaceutical products" industry. OS Therapies vs. Bright Minds Biosciences FitLife Brands Neoleukin Therapeutics Sagimet Biosciences Acumen Pharmaceuticals Puma Biotechnology Black Diamond Therapeutics Inventiva Innate Pharma Cidara Therapeutics OS Therapies (NYSE:OSTX) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Do analysts prefer OSTX or DRUG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OS Therapies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in OSTX or DRUG? 40.5% of Bright Minds Biosciences shares are owned by institutional investors. 42.7% of Bright Minds Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is OSTX or DRUG more profitable? OS Therapies' return on equity of 0.00% beat Bright Minds Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets OS TherapiesN/A N/A -569.57% Bright Minds Biosciences N/A -58.55%-53.79% Which has higher valuation and earnings, OSTX or DRUG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOS TherapiesN/AN/A-$7.79MN/AN/ABright Minds BiosciencesN/AN/A-$5.47M-$0.68-48.90 Does the media refer more to OSTX or DRUG? In the previous week, OS Therapies had 2 more articles in the media than Bright Minds Biosciences. MarketBeat recorded 3 mentions for OS Therapies and 1 mentions for Bright Minds Biosciences. Bright Minds Biosciences' average media sentiment score of 0.00 beat OS Therapies' score of -0.91 indicating that Bright Minds Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OS Therapies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative Bright Minds Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor OSTX or DRUG? OS Therapies received 2 more outperform votes than Bright Minds Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformOS TherapiesOutperform Votes2100.00% Underperform VotesNo VotesBright Minds BiosciencesN/AN/A SummaryOS Therapies and Bright Minds Biosciences tied by winning 5 of the 10 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get OS Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSTX vs. The Competition Export to ExcelMetricOS TherapiesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$36.96M$6.44B$5.05B$19.89BDividend YieldN/A8.11%5.17%3.54%P/E RatioN/A10.61125.0842.83Price / SalesN/A243.751,182.0518.13Price / CashN/A22.1633.7217.86Price / BookN/A5.474.685.52Net Income-$7.79M$153.61M$119.45M$986.45M7 Day Performance-30.95%-4.32%-2.46%-0.22%1 Month Performance-42.33%-8.61%-4.08%0.12%1 Year PerformanceN/A28.79%29.81%23.71% OS Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSTXOS TherapiesN/A$1.74-1.7%N/AN/A$36.96MN/A0.00N/AHigh Trading VolumeDRUGBright Minds Biosciences0.8622 of 5 stars$33.25+1.8%N/A+2,513.4%$147.30MN/A0.00N/AFTLFFitLife Brands4.0645 of 5 stars$31.83+2.3%$40.00+25.7%+59.9%$146.42M$52.70M18.8320Analyst RevisionNLTXNeoleukin TherapeuticsN/A$15.33-11.0%N/A+30.5%$144.07MN/A-4.9390High Trading VolumeSGMTSagimet Biosciences2.1861 of 5 stars$4.65+2.9%$21.60+364.5%+50.2%$142.62M$2M0.008ABOSAcumen Pharmaceuticals2.6635 of 5 stars$2.37-0.8%$9.00+279.7%+0.4%$142.39MN/A0.0051Analyst RevisionPBYIPuma Biotechnology4.4141 of 5 stars$2.89+1.8%$7.00+142.2%-27.0%$141.87M$235.60M5.92185Analyst ForecastPositive NewsBDTXBlack Diamond Therapeutics2.8436 of 5 stars$2.49+2.5%$15.50+522.5%+8.0%$140.88MN/A0.0090Positive NewsIVAInventiva3.0751 of 5 stars$2.61-4.7%$14.00+436.4%-31.9%$136.97M$18.91M0.00100News CoverageIPHAInnate Pharma2.2362 of 5 stars$1.69+13.5%$11.50+582.3%-32.8%$136.48M$66.71M0.00220News CoverageGap UpCDTXCidara Therapeutics4.1784 of 5 stars$19.30+27.6%$30.50+58.0%+0.9%$136.07M$63.90M0.0090 Related Companies and Tools Related Companies Bright Minds Biosciences Competitors FitLife Brands Competitors Neoleukin Therapeutics Competitors Sagimet Biosciences Competitors Acumen Pharmaceuticals Competitors Puma Biotechnology Competitors Black Diamond Therapeutics Competitors Inventiva Competitors Innate Pharma Competitors Cidara Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OSTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OS Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share OS Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OSTX Stock Alerts